Cite

    Francisco Cruz et al.. “Efficacy and safety of onabotulinumtoxina 100 U for treatment of urinary incontinence due to neurogenic detrusor overactivity in noncatheterizing multiple sclerosis patients.” Toxicon, vol. 123, n.d., pp. S19–. http://access.bl.uk/ark:/81055/vdc_100039991354.0x000041